StockClub
MAZEMaze Therapeutics, Inc.$ --
Maze Therapeutics, Inc.

Maze Therapeutics, Inc.

MAZE

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
0M USD
YoY -100.0%
Operating Income
-33M USD
YoY -36.1%
Net Income
-30M USD
YoY -21.6%
EPS
-0.66$
YoY -1091.3%

Revenue

$0
FY2023 Q4$0
$0
Q4
FY2024 Q1$0
$0
Q1
FY2024 Q2$165M
$165M
Q2
FY2024 Q3$167.5M
$167.5M
Q3
FY2024 Q4$167.5M
$167.5M
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
Actual
$-167.5M (-100.0%)

Net Income

$-96.6M
FY2023 Q4$-51.3M
$-51.3M
Q4
FY2024 Q1$-32.5M
$-32.5M
Q1
FY2024 Q2$106.6M
$106.6M
Q2
FY2024 Q3$81.8M
$81.8M
Q3
FY2024 Q4$52.2M
$52.2M
Q4
FY2025 Q1$-32.8M
$-32.8M
Q1
FY2025 Q2$-66.5M
$-66.5M
Q2
FY2025 Q3$-96.6M
$-96.6M
Q3
Actual
$-178.4M (-218.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024MISS
Actual:$167.5M
Est:$167.7M
FY2024MISS
$167.5M

Analyst Estimates